Recombinant Human MICAL1 Protein, N-His

Description of Recombinant Human MICAL1 Protein, N-His

Introduction

Recombinant Human MICAL1 Protein, also known as Microtubule-associated monooxygenase MICAL1, is a protein that plays a crucial role in regulating cell structure and function. It is a recombinant protein, which means it is produced through genetic engineering techniques in a laboratory setting. This protein has gained significant attention in the scientific community due to its potential in various biomedical applications. In this article, we will provide a detailed description of the structure, activity, and application of Recombinant Human MICAL1 Protein.

Structure of Recombinant Human MICAL1 Protein

Recombinant Human MICAL1 Protein is a 1,483 amino acid long protein with a molecular weight of approximately 170 kDa. It belongs to the MICAL family of proteins, which are highly conserved among different species. The MICAL1 protein contains several functional domains, including a calponin homology (CH) domain, a LIM domain, a coiled-coil domain, and a flavin adenine dinucleotide (FAD) binding domain. These domains play a crucial role in the protein’s function and interaction with other molecules.

Activity of Recombinant Human MICAL1 Protein

Recombinant Human MICAL1 Protein acts as a monooxygenase enzyme, which means it catalyzes the incorporation of oxygen into a substrate molecule. It uses oxygen and NADPH as co-substrates to oxidize its target molecules, such as actin and tubulin. This enzymatic activity of MICAL1 is regulated by its FAD binding domain, which acts as a redox sensor. The FAD domain undergoes a conformational change upon binding to NADPH, which activates the enzyme.

Moreover, MICAL1 also has a unique function in regulating actin and microtubule dynamics. It can directly bind to and sever actin filaments, leading to their disassembly. This activity is essential for cell migration, cell division, and other cellular processes that require actin remodeling. MICAL1 also interacts with microtubules and regulates their polymerization and stability, which is crucial for cell shape and movement.

Application of Recombinant Human MICAL1 Protein

Recombinant Human MICAL1 Protein has various potential applications in the biomedical field. Its role in regulating actin and microtubule dynamics makes it a potential target for cancer therapy. Cancer cells often have abnormal actin and microtubule structures, and targeting MICAL1 could disrupt these structures and inhibit cancer cell growth.

Moreover, MICAL1 has also been linked to neurodegenerative diseases, such as Alzheimer’s and Parkinson’s. Studies have shown that MICAL1 plays a role in the formation of toxic protein aggregates in these diseases. Therefore, targeting MICAL1 could potentially prevent or slow down the progression of these diseases.

Furthermore, MICAL1 has been implicated in cardiovascular diseases, such as atherosclerosis and hypertension. It plays a role in regulating smooth muscle cell contraction, which is critical for maintaining blood vessel tone. Targeting MICAL1 could potentially help in the treatment of these diseases.

In addition to its potential therapeutic applications, Recombinant Human MICAL1 Protein also has diagnostic uses. It has been identified as a potential biomarker for various diseases, including cancer and neurodegenerative diseases. Its levels in body fluids, such as blood and cerebrospinal fluid, could be used to diagnose and monitor disease progression.

Conclusion

In conclusion, Recombinant Human MICAL1 Protein is a multifunctional protein with a crucial role in regulating cell structure and function. Its unique enzymatic and regulatory activities make it a potential target for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. Moreover, it also has diagnostic applications, making it a promising protein for future research and development.